Documents
-
- Download
- Full text
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Analytical performance evaluation of the cardiac troponin T high sensitivity gen 6 assay
Background
High-sensitivity cardiac troponin (hs-cTn) assays are recommended for the diagnosis of acute myocardial infarction. Here, we characterize the analytical performance of a next-generation hs-cTn assay, Elecsys (R) Troponin T hs Gen 6 (Roche Diagnostics International).
Methods
Surplus lithium-heparin plasma or serum samples from patients or healthy volunteers were run on Cobas (R) e 801, e 402, and Pro analyzers. Limits of blank (LoB), limits of detection (LoD), and limits of quantitation (LoQ) were determined according to CLSI EP17-A2, with target values of 1.0 and 1.5 ng/L for LoB/LoD and 3.0 ng/L (10% CV) and 1.5 ng/L (20% CV) for LoQ, respectively. Precision was measured, per CLSI EP17-A2, using 3 QC samples (approximately 4, 30, and 220 ng/L), 12 native samples, and 3 reagent lots. Linearity, per CLSI EP06-Ed2, was determined by diluting samples with cardiac troponin T (cTnT) concentration above the measuring range with a low/blank...
Show moreBackground
High-sensitivity cardiac troponin (hs-cTn) assays are recommended for the diagnosis of acute myocardial infarction. Here, we characterize the analytical performance of a next-generation hs-cTn assay, Elecsys (R) Troponin T hs Gen 6 (Roche Diagnostics International).
Methods
Surplus lithium-heparin plasma or serum samples from patients or healthy volunteers were run on Cobas (R) e 801, e 402, and Pro analyzers. Limits of blank (LoB), limits of detection (LoD), and limits of quantitation (LoQ) were determined according to CLSI EP17-A2, with target values of 1.0 and 1.5 ng/L for LoB/LoD and 3.0 ng/L (10% CV) and 1.5 ng/L (20% CV) for LoQ, respectively. Precision was measured, per CLSI EP17-A2, using 3 QC samples (approximately 4, 30, and 220 ng/L), 12 native samples, and 3 reagent lots. Linearity, per CLSI EP06-Ed2, was determined by diluting samples with cardiac troponin T (cTnT) concentration above the measuring range with a low/blank sample. Interference (per Glick) with endogenous and assay components at 5 cTnT concentrations was assessed.
Results
Measured values for LoB, LoD, and LoQ at 10% and 20% CV were 0.1 to 0.7 ng/L, 0.3 to 1.4 ng/L, 1.0 to 2.9 ng/L, and 0.4 to 1.2 ng/L, respectively. Repeatability CVs were 1.0 to 5.8% for mean cTnT concentrations of 2.6 to 9230 ng/L in lithium-heparin plasma. High precision was shown across lots, and linearity was observed across the measuring range (1.5 to 9500 ng/L, all Pearson's r = 1.00). No interferences were observed, specified up to <= 1000 mg/dL hemoglobin, <= 50 mg/dL [<= 855 & micro;mol/L] icterus/bilirubin, and <= 1200 ng/mL biotin.
Conclusions The analytical performance characterization of the assay demonstrated high sensitivity, high precision at the low end and across the measuring range, and resistance to interference.
- All authors
- Knoll, M.; Daniels, L.B.; Mueller, C.; Mills, N.L.; Giannitsis, E.; Rösser, A.F.A.; Kurtoic, D.; Wahl, A.; Body, R.; Christenson, R.H.; Cobbaert, C.; deFilippi, C.R.; Eggers, K.M.; Inoue, K.; Jaffe, A.S.; McCarthy, C.P.; McCord, J.; Neumann, J.T.; Omland, T.; Papendick, C.; Sandoval, Y.; Tan, J.W.C.; Than, M.P.; Twerenbold, R.; Peacock, W.F.; Meex, S.J.R.
- Date
- 2026-03-26